CNBC   |  October 23, 2013

Eli Lilly's Q3 beats on top and bottom line

We had strong revenue growth of six-percent, and three-percent of that growth was volume driven, says Derica Rice, Eli Lilly CFO, breaking down his company's Q3 results and discussing several products the drugmaker has in the pipeline and growth areas ...

Share This:

Sorry, we do not have a transcript available for this video at this time.